Erratum to Retraction notice to "Common genetic variants in the microRNA biogenesis pathway are associated with malignant peripheral nerve sheath tumor risk in a Chinese population" [Cancer Epidemiol. 37 (2013) 913-916] doi: 10.1016/j.canep.2013.05.003;Common genetic variants in the microRNA biogenesis pathway are associated with malignant peripheral nerve sheath tumor risk in a Chinese population

Cancer Epidemiology

Volumn 37, Issue 6, 2013, Pages 913-916

  Weng, Yuxiong ^a   Chen, Yanhua ^a   Chen, Jianghai ^a   Liu, Yutian ^a   Bao, Tengfei ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Genetic variants; MiRNA; MPNST

Indexed keywords

MICRORNA;

ADULT; AGO2 GENE; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINESE; DDX5 GENE; DROSHA GENE; FEMALE; GEMIN4 GENE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; NEUROFIBROMATOSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

95% CI; 95% CONFIDENCE INTERVALS; GENETIC VARIANTS; MALIGNANT PERIPHERAL NERVE SHEATH TUMORS; MICRORNA; MIRNA; MPNST; NEUROFIBROMATOSIS TYPE 1; NF1; ODDS RATIOS; OR; PRI-MIRNA; PRIMARY PRECURSORS;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; MICRORNAS; NEURILEMMOMA; NEUROFIBROMATOSIS 1; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84888308312     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2015.07.006     Document Type: Erratum

References (35)

1. Brems H., Beert E., de Ravel T., Legius E. Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol 2009, 10(5):508-515.
2. Katz D., Lazar A., Lev D. Malignant peripheral nerve sheath tumour (MPNST): the clinical implications of cellular signalling pathways. Expert Rev Mol Med 2009, 11e30.
3. Evans D.G., Baser M.E., McGaughran J., Sharif S., Howard E., Moran A. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 2002, 39(5):311-314.
4. Iorio M.V., Croce C.M. microRNA involvement in human cancer. Carcinogenesis 2012, 33(6):1126-1133.
5. Wang Z., Liu Y., Han N., Chen X., Yu W., Zhang W., et al. Profiles of oxidative stress-related microRNA and mRNA expression in auditory cells. Brain Res 2010, 134614-134625.
6. O'Connell R.M., Rao D.S., Baltimore D. microRNA regulation of inflammatory responses. Annu Rev Immunol 2012, 30295-30312.
7. Wang P., Zou F., Zhang X., Li H., Dulak A., Tomko R.J., et al. microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res 2009, 69(20):8157-8165.
8. Lin Y.-X., Yu F., Gao N., Sheng J.-P., Qiu J.-Z., Hu B.-C. microRNA-143 protects cells from DNA damage-induced killing by downregulating FHIT expression. Cancer Biother Radiopharm 2011, 26(3):365-372.
9. Calin G.A., Ferracin M., Cimmino A., Di Leva G., Shimizu M., Wojcik S.E., et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005, 353(17):1793-1801.
10. Schetter A.J., Leung S.Y., Sohn J.J., Zanetti K.A., Bowman E.D., Yanaihara N., et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008, 299(4):425-436.
11. Chai G., Liu N., Ma J., Li H., Oblinger J.L., Prahalad A.K., et al. MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1. Cancer Sci 2010, 101(9):1997-2004.
12. Itani S., Kunisada T., Morimoto Y., Yoshida A., Sasaki T., Ito S., et al. MicroRNA-21 correlates with tumorigenesis in malignant peripheral nerve sheath tumor (MPNST) via programmed cell death protein 4 (PDCD4). J Cancer Res Clin Oncol 2012, 138(9):1501-1509.
13. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat Rev Cancer 2006, 6(11):857-866.
14. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Cancer 2010, 11(9):597-610.
15. Ryan B.M., Robles A.I., Harris C.C. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 2010, 10(6):389-402.
16. Hill D.A., Ivanovich J., Priest J.R., Gurnett C.A., Dehner L.P., Desruisseau D., et al. DICER1 mutations in familial pleuropulmonary blastoma. Science 2009, 325(5943):965.
17. Heravi-Moussavi A., Anglesio M.S., Cheng S.W.G., Senz J., Yang W., Prentice L., et al. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. New Engl J Med 2012, 366(3):234-242.
18. Lee H.-C., Kim J.G., Chae Y.S., Sohn S.K., Kang B.W., Moon J.H., et al. Prognostic impact of microRNA-related gene polymorphisms on survival of patients with colorectal cancer. J Cancer Res Clin Oncol 2010, 136(7):1073-1078.
19. Yang H., Dinney C.P., Ye Y., Zhu Y., Grossman H.B., Wu X. Evaluation of genetic variants in MicroRNA-related genes and risk of bladder cancer. Cancer Res 2008, 68(7):2530-2537.
20. Lin J., Horikawa Y., Tamboli P., Clague J., Wood C.G., Wu X. Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis 2010, 31(10):1805-1812.
21. Liang D., Meyer L., Chang D.W., Lin J., Pu X., Ye Y., et al. Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response. Cancer Res 2010, 70(23):9765-9776.
22. Zhang X., Yang H., Lee J.J., Kim E., Lippman S.M., Khuri F.R., et al. MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer. Carcinogenesis 2010, 31(12):2118-2123.
23. Ma H., Yuan H., Yuan Z., Yu C., Wang R., Jiang Y., et al. Genetic variations in key microRNA processing genes and risk of head and neck cancer: a case-control study in Chinese population. PloS ONE 2012, 7(10):e47544.
24. Liu J., Wei M., He Y., Liao B., Liao G., Li H., et al. Genetic variants in the microRNA machinery gene GEMIN4 are associated with risk of prostate cancer: a case-control study of the Chinese Han population. DNA Cell Biol 2012, 31(7):1296-1302.
25. Clague J., Lippman S.M., Yang H., Hildebrandt M.A., Ye Y., Lee J.J., et al. Genetic variation in MicroRNA genes and risk of oral premalignant lesions. Mol Carcinog 2010, 49(2):183-189.
26. Sung H., Jeon S., Lee K.M., Han S., Song M., Choi J.Y., et al. Common genetic polymorphisms of microRNA biogenesis pathway genes and breast cancer survival. BMC Cancer 2012, 12(1):195.
27. Sung H., Lee K.M., Choi J.Y., Han S., Lee J.Y., Li L., et al. Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea. Breast Cancer Res Treat 2011, 130(3):939-951.
28. Sung H., Zhang B., Choi J.Y., Long J., Park S.K., Yoo K.Y., et al. Common genetic variants in the microRNA biogenesis pathway are not associated with breast cancer risk in Asian women. Cancer Epidemiol Biomarkers Prev 2012, 21(8):1385-1387.
29. Gutmann D.H., Aylsworth A., Carey J.C., Korf B., Marks J., Pyeritz R.E., et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997, 278(1):51-57.
30. Fukuda T., Yamagata K., Fujiyama S., Matsumoto T., Koshida I., Yoshimura K., et al. DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs. Nat Cell Biol 2007, 9(5):604-611.
31. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425(6956):415-419.
32. Muralidhar B., Goldstein L.D., Ng G., Winder D.M., Palmer R.D., Gooding E.L., et al. Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels. J Pathol 2007, 212(4):368-377.
33. Kim M.S., Oh J.E., Kim Y.R., Park S.W., Kang M.R., Kim S.S., et al. Somatic mutations and losses of expression of microRNA regulation-related genes AGO2 and TNRC6A in gastric and colorectal cancers. J Pathol 2010, 221(2):139-146.
34. Horikawa Y., Wood C.G., Yang H., Zhao H., Ye Y., Gu J., et al. Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin Cancer Res 2008, 14(23):7956-7962.
35. Sorensen S.A., Mulvihill J.J., Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med 1986, 314(16):1010-1015.